drugset / Trial / NCT00911313

Letrozole or Combined Metformin Clomiphene Citrate (CC) for Women With CC Resistant Polycystic Ovary Syndrome

NCT00911313

Completed 250 enrolled Mansoura University
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to compare and determine the efficacy of letrozole administration to that of combined metformin and Clomiphene in infertile women with polycystic ovary syndrome (PCOS) not responding to treatment with Clomiphene alone.

Timeline

Start
2006-06
Primary completion
2009-01
Completion
2009-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Clomiphene Other / unclassified 150 mg
Subject Letrozole Other / unclassified 2.5 mg Oral
Comparator Metformin Small molecule 500 mg